Literature DB >> 21246579

Does laser type impact myocardial function following transmyocardial laser revascularization?

Soren K Estvold1, Frederico Mordini, Yifu Zhou, Zu X Yu, Vandana Sachdev, Andrew Arai, Keith A Horvath.   

Abstract

BACKGROUND: Transmyocardial laser revascularization (TMR) is currently clinically performed with either a CO(2) or Ho:YAG laser for the treatment of severe angina. While both lasers provide symptomatic relief, there are significant differences in the laser-tissue interactions specific to each device that may impact their ability to enhance the perfusion of myocardium and thereby improve contractile function of the ischemic heart.
METHODS: A porcine model of chronic myocardial ischemia was employed. After collecting baseline functional data with cine magnetic resonance imaging (MRI) and dobutamine stress echo (DSE), 14 animals underwent TMR with either a CO(2) or Ho:YAG laser. Transmural channels were created with each laser in a distribution of 1/cm(2) in the ischemic zone. Six weeks post-treatment repeat MRI as well as DSE were obtained after which the animals were sacrificed. Histology was preformed to characterize the laser-tissue interaction.
RESULTS: CO(2) TMR led to improvement in wall thickening in the ischemic area as seen with cine MRI (40.3% vs. baseline, P < 0.05) and DSE (20.2% increase vs. baseline, P < 0.05). Ho:YAG treated animals had no improvement in wall thickening by MRI (-11.6% vs. baseline, P = .67) and DSE (-16.7% vs. baseline, P = 0.08). Correlative semi-quantitative histology revealed a significantly higher fibrosis index in Ho:YAG treated myocardium versus CO(2) (1.81 vs. 0.083, P < 0.05).
CONCLUSIONS: In a side-by-side comparison CO(2) TMR resulted in improved function of ischemic myocardium as assessed by MRI and echocardiography. Ho:YAG TMR led to no improvement in regional function likely due to concomitant increase in fibrosis in the lasered area.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21246579      PMCID: PMC3411323          DOI: 10.1002/lsm.21012

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  23 in total

Review 1.  Mechanisms and results of transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  Cardiology       Date:  2004       Impact factor: 1.869

2.  Transmyocardial laser revascularization with the Holmium:YAG laser does not improve myocardial perfusion in the acutely ischemic heart: an experimental study measuring myocardial perfusion by a thermal imaging camera.

Authors:  F S Eckstein; A M Scheule; Y Pauncz; S T Schmid; M Zucker; G Ziemer
Journal:  Thorac Cardiovasc Surg       Date:  1999-10       Impact factor: 1.827

Review 3.  A proposed alternative mechanism of action for transmyocardial revascularization prefaced by a review of the accepted explanations.

Authors:  Marcelo Cardarelli
Journal:  Tex Heart Inst J       Date:  2006

Review 4.  Transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  J Card Surg       Date:  2008 May-Jun       Impact factor: 1.620

5.  Extent of myocardial tissue damage during transmyocardial laser revascularization with the CO2 Heart Laser.

Authors:  T Krabatsch; R Petzina; R Baretti; H Hausmann; R Hetzer
Journal:  J Clin Laser Med Surg       Date:  2001-10

6.  Functional comparison of transmyocardial revascularization by mechanical and laser means.

Authors:  K A Horvath; N Belkind; I Wu; R Greene; J Doukas; J W Lomasney; D D McPherson; D A Fullerton
Journal:  Ann Thorac Surg       Date:  2001-12       Impact factor: 4.330

7.  Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser.

Authors:  K A Horvath; S F Aranki; L H Cohn; R J March; O H Frazier; K A Kadipasaoglu; S W Boyce; B W Lytle; K P Landolfo; J E Lowe; B Hattler; B P Griffith; A M Lansing
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

8.  Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial.

Authors:  L Aaberge; K Nordstrand; M Dragsund; K Saatvedt; K Endresen; S Golf; O Geiran; M Abdelnoor; K Forfang
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

9.  Experimental investigations on relationships between myocardial damage and laser type used in transmyocardial laser revascularization (TMLR).

Authors:  T Kitade; M Okada; Y Tsuji; M Nakamura; Y Matoba
Journal:  Kobe J Med Sci       Date:  1999-08

10.  Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial.

Authors:  K B Allen; R D Dowling; A J DelRossi; F Realyvasques; E A Lefrak; T A Pfeffer; T L Fudge; M Mostovych; D Schuch; S Szentpetery; C J Shaar
Journal:  J Thorac Cardiovasc Surg       Date:  2000-03       Impact factor: 5.209

View more
  4 in total

1.  Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF-C-kit and SDF-1-CXCR4 Signaling Axes.

Authors:  Uswa Shahzad; Guangming Li; Yaoguang Zhang; Ren-Ke Li; Vivek Rao; Terrence M Yau
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

2.  A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor.

Authors:  Karen J Keeran; Kenneth R Jeffries; Arthur D Zetts; Joni Taylor; Shawn Kozlov; Timothy J Hunt
Journal:  J Vis Exp       Date:  2017-10-09       Impact factor: 1.355

Review 3.  Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.

Authors:  Jessika Iwanski; Shannon M Knapp; Ryan Avery; Isabel Oliva; Raymond K Wong; Raymond B Runyan; Zain Khalpey
Journal:  J Cardiothorac Surg       Date:  2017-05-19       Impact factor: 1.637

Review 4.  Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy.

Authors:  Jessika Iwanski; Raymond K Wong; Douglas F Larson; Alice S Ferng; Raymond B Runyan; Steven Goldstein; Zain Khalpey
Journal:  Springerplus       Date:  2016-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.